Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expanding the HTS paradigm

James Inglese

    Drug Discovery Today
    |January 28, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chemoselective Halogenation of Premarineosin A for Next-Generation Antimalarial Development.

    bioRxiv : the preprint server for biology·2026
    Same author

    A fission yeast-based platform for nematode PDE inhibitor discovery.

    Cellular signalling·2026
    Same author

    Metabolic engineering and late-stage functionalization expand the chemical space of the antimalarial premarineosin A.

    Communications chemistry·2025
    Same author

    Cyclic peptides as ligands for competition binding assays.

    Methods in enzymology·2025
    Same author

    Pharmacologic activation of Δ133p53α reduces cellular senescence in progeria patients-derived cells.

    Aging pathobiology and therapeutics·2025
    Same author

    Pharmacologic activation of Δ133p53α reduces cellular senescence in progeria patients-derived cells.

    bioRxiv : the preprint server for biology·2025
    Same journal

    Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

    Drug discovery today·2026
    Same journal

    HDAC11 as a potential therapeutic target for Alzheimer's disease.

    Drug discovery today·2026
    Same journal

    From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

    Drug discovery today·2026
    Same journal

    Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

    Drug discovery today·2026
    Same journal

    Chemical intervention strategies targeting MYC for cancer therapy.

    Drug discovery today·2026
    Same journal

    How many protein pairs can we chemically target?

    Drug discovery today·2026
    See all related articles